Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (198)	7/8/1997 4:01:00 PM
From: Sleepman	of 10280

I would love to review the data of their phase III trial to see how different the drugs are. In prescribing a drug, a physician must take many things into account. Efficacy, side effect, drug interaction profile, and cost all must be taken into account. If the efficacy is marginally different, and the side effect profile also is different, then, it is not wrong to make a choice that is significantly cheaper. There are lots of examples of this process on a daily basis in every hospital. Don't get me wrong, I am eyeing SEPR for several reasons, but this is a concern of mine. I am also trying to figure out what a fair price to pay is. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next